CSF2 and cancer: The intratumoral administration of this engineered HSV prompts cancer cells to produce extended levels of GM-CSF locally, which attracts antigen-presenting cells through chemotaxis, initiating a local adaptive immune response to tumor antigens capable of cancer distant from the infusion site.